238 related articles for article (PubMed ID: 31280965)
1. 2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: long-term follow-up of a multicentre, randomised trial.
Utjés D; Malmstedt J; Teras J; Drzewiecki K; Gullestad HP; Ingvar C; Eriksson H; Gillgren P
Lancet; 2019 Aug; 394(10197):471-477. PubMed ID: 31280965
[TBL] [Abstract][Full Text] [Related]
2. Wide versus narrow excision margins for high-risk, primary cutaneous melanomas: long-term follow-up of survival in a randomised trial.
Hayes AJ; Maynard L; Coombes G; Newton-Bishop J; Timmons M; Cook M; Theaker J; Bliss JM; Thomas JM; ; ;
Lancet Oncol; 2016 Feb; 17(2):184-192. PubMed ID: 26790922
[TBL] [Abstract][Full Text] [Related]
3. 2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: a randomised, multicentre trial.
Gillgren P; Drzewiecki KT; Niin M; Gullestad HP; Hellborg H; Månsson-Brahme E; Ingvar C; Ringborg U
Lancet; 2011 Nov; 378(9803):1635-42. PubMed ID: 22027547
[TBL] [Abstract][Full Text] [Related]
4. 1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility Study.
Moncrieff MD; Gyorki D; Saw R; Spillane AJ; Thompson JF; Peach H; Oudit D; Geh J; Dziewulski P; Wilson E; Matteucci P; Pritchard-Jones R; Olofsson Bagge R; Wright FC; Crampton N; Cassell O; Jallali N; Berger A; Kelly J; Hamilton S; Durrani A; Lo S; Paton E; Henderson MA
Ann Surg Oncol; 2018 Sep; 25(9):2541-2549. PubMed ID: 29850955
[TBL] [Abstract][Full Text] [Related]
5. Surgical excision margins for primary cutaneous melanoma.
Sladden MJ; Balch C; Barzilai DA; Berg D; Freiman A; Handiside T; Hollis S; Lens MB; Thompson JF
Cochrane Database Syst Rev; 2009 Oct; (4):CD004835. PubMed ID: 19821334
[TBL] [Abstract][Full Text] [Related]
6. Optimal excision margins for primary cutaneous melanoma: a systematic review and meta-analysis.
Haigh PI; DiFronzo LA; McCready DR
Can J Surg; 2003 Dec; 46(6):419-26. PubMed ID: 14680348
[TBL] [Abstract][Full Text] [Related]
7. Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas.
Balch CM; Soong SJ; Smith T; Ross MI; Urist MM; Karakousis CP; Temple WJ; Mihm MC; Barnhill RL; Jewell WR; Wanebo HJ; Desmond R;
Ann Surg Oncol; 2001 Mar; 8(2):101-8. PubMed ID: 11258773
[TBL] [Abstract][Full Text] [Related]
8. Surgical margins for excision of primary cutaneous melanoma.
Zitelli JA; Brown CD; Hanusa BH
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):422-9. PubMed ID: 9308558
[TBL] [Abstract][Full Text] [Related]
9. Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006).
Schachter J; Ribas A; Long GV; Arance A; Grob JJ; Mortier L; Daud A; Carlino MS; McNeil C; Lotem M; Larkin J; Lorigan P; Neyns B; Blank C; Petrella TM; Hamid O; Zhou H; Ebbinghaus S; Ibrahim N; Robert C
Lancet; 2017 Oct; 390(10105):1853-1862. PubMed ID: 28822576
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial.
Burmeister BH; Henderson MA; Ainslie J; Fisher R; Di Iulio J; Smithers BM; Hong A; Shannon K; Scolyer RA; Carruthers S; Coventry BJ; Babington S; Duprat J; Hoekstra HJ; Thompson JF
Lancet Oncol; 2012 Jun; 13(6):589-97. PubMed ID: 22575589
[TBL] [Abstract][Full Text] [Related]
11. A retrospective study of 1- versus 2-cm excision margins for cutaneous malignant melanomas thicker than 2 mm.
Hunger RE; Angermeier S; Seyed Jafari SM; Ochsenbein A; Shafighi M
J Am Acad Dermatol; 2015 Jun; 72(6):1054-9. PubMed ID: 25877659
[TBL] [Abstract][Full Text] [Related]
12. Excision margins in high-risk malignant melanoma.
Thomas JM; Newton-Bishop J; A'Hern R; Coombes G; Timmons M; Evans J; Cook M; Theaker J; Fallowfield M; O'Neill T; Ruka W; Bliss JM; ; ;
N Engl J Med; 2004 Feb; 350(8):757-66. PubMed ID: 14973217
[TBL] [Abstract][Full Text] [Related]
13. Histopathologic excision margin affects local recurrence rate: analysis of 2681 patients with melanomas < or =2 mm thick.
McKinnon JG; Starritt EC; Scolyer RA; McCarthy WH; Thompson JF
Ann Surg; 2005 Feb; 241(2):326-33. PubMed ID: 15650644
[TBL] [Abstract][Full Text] [Related]
14. Excision Margin and Survival in Patients with High-Risk, Primary Cutaneous Melanoma: A Retrospective Study Based on Surveillance Epidemiology and End Result (SEER) Database.
Xu MN; Rao Q
Dermatology; 2022; 238(3):534-541. PubMed ID: 34818654
[TBL] [Abstract][Full Text] [Related]
15. Long term results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8-2.0 mm.
Cohn-Cedermark G; Rutqvist LE; Andersson R; Breivald M; Ingvar C; Johansson H; Jönsson PE; Krysander L; Lindholm C; Ringborg U
Cancer; 2000 Oct; 89(7):1495-501. PubMed ID: 11013363
[TBL] [Abstract][Full Text] [Related]
16. Sentinel node location in trunk and extremity melanomas: uncommon or multiple lymph drainage does not affect survival.
Gordon D; Smedby KE; Schultz I; Olsson H; Ingvar C; Hansson J; Gillgren P
Ann Surg Oncol; 2014 Oct; 21(11):3386-94. PubMed ID: 24866434
[TBL] [Abstract][Full Text] [Related]
17. Surgical excision margin for primary acral melanoma.
Lee KT; Kim EJ; Lee DY; Kim JH; Jang KT; Mun GH
J Surg Oncol; 2016 Dec; 114(8):933-939. PubMed ID: 27642170
[TBL] [Abstract][Full Text] [Related]
18. Resection margins of 2 versus 5 cm for cutaneous malignant melanoma with a tumor thickness of 0.8 to 2.0 mm: randomized study by the Swedish Melanoma Study Group.
Ringborg U; Andersson R; Eldh J; Glaumann B; Hafström L; Jacobsson S; Jönsson PE; Johansson H; Krysander L; Lagerlöf B
Cancer; 1996 May; 77(9):1809-14. PubMed ID: 8646678
[TBL] [Abstract][Full Text] [Related]
19. Narrow excision (1-cm margin). A safe procedure for thin cutaneous melanoma.
Veronesi U; Cascinelli N
Arch Surg; 1991 Apr; 126(4):438-41. PubMed ID: 2009058
[TBL] [Abstract][Full Text] [Related]
20. Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial.
Leiter U; Stadler R; Mauch C; Hohenberger W; Brockmeyer N; Berking C; Sunderkötter C; Kaatz M; Schulte KW; Lehmann P; Vogt T; Ulrich J; Herbst R; Gehring W; Simon JC; Keim U; Martus P; Garbe C;
Lancet Oncol; 2016 Jun; 17(6):757-767. PubMed ID: 27161539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
